A new highly effective shout-term therapy schedule for Helicobacter pylori eradication

A. Zullo, V. Rinaldi, S. Winn, P. Meddi, R. Lionetti, C. Hassan, C. Ripani, G. Tomaselli, A. F. Attili

Research output: Contribution to journalArticle

Abstract

Background: Although triple therapy regimens suggested in the Current European guidelines give fairly good results, several studies have reported an unsatisfactory Helicobacter pylori eradication rate (<80%). Aim: To evaluate the efficacy of a new short-term treatment sequence on H. pylori eradication. Methods: A total of 52 patients with H. pylori infection and either non-ulcer dyspepsia (34 patients) or peptic ulcer (18 patients) were enrolled to receive a 10-day therapy: omeprazole 20 mg b.d. plus amoxycillin 1 g b.d. for the first 5 days, followed by omeprazole 20 mg b.d., clarithromycin 500 mg b.d. and tinidazole 500 mg b.d, for the remaining 5 days. H. pylori infection at entry was assessed by rapid urease test and histology on biopsies from the antrum and the corpus. Bacterial eradication was assessed by endoscopy (peptic ulcer patients) or 13C urea breath test (non-ulcer dyspepsia patients) 4-6 weeks after therapy had ended. Results: All patients completed the study. H. pylori eradication was achieved in all but one patient, with an eradication rate of 98% (95% CI: 94.3-100) with intention-to-treat analysis. Patient compliance wits good (consumption of prescribed drugs > 95%) for all but one patient, who took the triple therapy regimen for 4 days instead of 5 days. No major side-effects were reported but three (6%) patients complained of mild side-effects. Conclusions: The use of this 'five plus five' therapy schedule as an initial treatment for H. pylori deserves further investigation.

Original languageEnglish
Pages (from-to)715-718
Number of pages4
JournalAlimentary Pharmacology and Therapeutics
Volume14
Issue number6
DOIs
Publication statusPublished - 2000

Fingerprint

Helicobacter pylori
Appointments and Schedules
Therapeutics
Guidelines

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

A new highly effective shout-term therapy schedule for Helicobacter pylori eradication. / Zullo, A.; Rinaldi, V.; Winn, S.; Meddi, P.; Lionetti, R.; Hassan, C.; Ripani, C.; Tomaselli, G.; Attili, A. F.

In: Alimentary Pharmacology and Therapeutics, Vol. 14, No. 6, 2000, p. 715-718.

Research output: Contribution to journalArticle

Zullo, A, Rinaldi, V, Winn, S, Meddi, P, Lionetti, R, Hassan, C, Ripani, C, Tomaselli, G & Attili, AF 2000, 'A new highly effective shout-term therapy schedule for Helicobacter pylori eradication', Alimentary Pharmacology and Therapeutics, vol. 14, no. 6, pp. 715-718. https://doi.org/10.1046/j.1365-2036.2000.00766.x
Zullo, A. ; Rinaldi, V. ; Winn, S. ; Meddi, P. ; Lionetti, R. ; Hassan, C. ; Ripani, C. ; Tomaselli, G. ; Attili, A. F. / A new highly effective shout-term therapy schedule for Helicobacter pylori eradication. In: Alimentary Pharmacology and Therapeutics. 2000 ; Vol. 14, No. 6. pp. 715-718.
@article{6e5ff366861c4041b75c8c850f19e027,
title = "A new highly effective shout-term therapy schedule for Helicobacter pylori eradication",
abstract = "Background: Although triple therapy regimens suggested in the Current European guidelines give fairly good results, several studies have reported an unsatisfactory Helicobacter pylori eradication rate (<80{\%}). Aim: To evaluate the efficacy of a new short-term treatment sequence on H. pylori eradication. Methods: A total of 52 patients with H. pylori infection and either non-ulcer dyspepsia (34 patients) or peptic ulcer (18 patients) were enrolled to receive a 10-day therapy: omeprazole 20 mg b.d. plus amoxycillin 1 g b.d. for the first 5 days, followed by omeprazole 20 mg b.d., clarithromycin 500 mg b.d. and tinidazole 500 mg b.d, for the remaining 5 days. H. pylori infection at entry was assessed by rapid urease test and histology on biopsies from the antrum and the corpus. Bacterial eradication was assessed by endoscopy (peptic ulcer patients) or 13C urea breath test (non-ulcer dyspepsia patients) 4-6 weeks after therapy had ended. Results: All patients completed the study. H. pylori eradication was achieved in all but one patient, with an eradication rate of 98{\%} (95{\%} CI: 94.3-100) with intention-to-treat analysis. Patient compliance wits good (consumption of prescribed drugs > 95{\%}) for all but one patient, who took the triple therapy regimen for 4 days instead of 5 days. No major side-effects were reported but three (6{\%}) patients complained of mild side-effects. Conclusions: The use of this 'five plus five' therapy schedule as an initial treatment for H. pylori deserves further investigation.",
author = "A. Zullo and V. Rinaldi and S. Winn and P. Meddi and R. Lionetti and C. Hassan and C. Ripani and G. Tomaselli and Attili, {A. F.}",
year = "2000",
doi = "10.1046/j.1365-2036.2000.00766.x",
language = "English",
volume = "14",
pages = "715--718",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "6",

}

TY - JOUR

T1 - A new highly effective shout-term therapy schedule for Helicobacter pylori eradication

AU - Zullo, A.

AU - Rinaldi, V.

AU - Winn, S.

AU - Meddi, P.

AU - Lionetti, R.

AU - Hassan, C.

AU - Ripani, C.

AU - Tomaselli, G.

AU - Attili, A. F.

PY - 2000

Y1 - 2000

N2 - Background: Although triple therapy regimens suggested in the Current European guidelines give fairly good results, several studies have reported an unsatisfactory Helicobacter pylori eradication rate (<80%). Aim: To evaluate the efficacy of a new short-term treatment sequence on H. pylori eradication. Methods: A total of 52 patients with H. pylori infection and either non-ulcer dyspepsia (34 patients) or peptic ulcer (18 patients) were enrolled to receive a 10-day therapy: omeprazole 20 mg b.d. plus amoxycillin 1 g b.d. for the first 5 days, followed by omeprazole 20 mg b.d., clarithromycin 500 mg b.d. and tinidazole 500 mg b.d, for the remaining 5 days. H. pylori infection at entry was assessed by rapid urease test and histology on biopsies from the antrum and the corpus. Bacterial eradication was assessed by endoscopy (peptic ulcer patients) or 13C urea breath test (non-ulcer dyspepsia patients) 4-6 weeks after therapy had ended. Results: All patients completed the study. H. pylori eradication was achieved in all but one patient, with an eradication rate of 98% (95% CI: 94.3-100) with intention-to-treat analysis. Patient compliance wits good (consumption of prescribed drugs > 95%) for all but one patient, who took the triple therapy regimen for 4 days instead of 5 days. No major side-effects were reported but three (6%) patients complained of mild side-effects. Conclusions: The use of this 'five plus five' therapy schedule as an initial treatment for H. pylori deserves further investigation.

AB - Background: Although triple therapy regimens suggested in the Current European guidelines give fairly good results, several studies have reported an unsatisfactory Helicobacter pylori eradication rate (<80%). Aim: To evaluate the efficacy of a new short-term treatment sequence on H. pylori eradication. Methods: A total of 52 patients with H. pylori infection and either non-ulcer dyspepsia (34 patients) or peptic ulcer (18 patients) were enrolled to receive a 10-day therapy: omeprazole 20 mg b.d. plus amoxycillin 1 g b.d. for the first 5 days, followed by omeprazole 20 mg b.d., clarithromycin 500 mg b.d. and tinidazole 500 mg b.d, for the remaining 5 days. H. pylori infection at entry was assessed by rapid urease test and histology on biopsies from the antrum and the corpus. Bacterial eradication was assessed by endoscopy (peptic ulcer patients) or 13C urea breath test (non-ulcer dyspepsia patients) 4-6 weeks after therapy had ended. Results: All patients completed the study. H. pylori eradication was achieved in all but one patient, with an eradication rate of 98% (95% CI: 94.3-100) with intention-to-treat analysis. Patient compliance wits good (consumption of prescribed drugs > 95%) for all but one patient, who took the triple therapy regimen for 4 days instead of 5 days. No major side-effects were reported but three (6%) patients complained of mild side-effects. Conclusions: The use of this 'five plus five' therapy schedule as an initial treatment for H. pylori deserves further investigation.

UR - http://www.scopus.com/inward/record.url?scp=0034129259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034129259&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2036.2000.00766.x

DO - 10.1046/j.1365-2036.2000.00766.x

M3 - Article

C2 - 10848654

AN - SCOPUS:0034129259

VL - 14

SP - 715

EP - 718

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 6

ER -